Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
CHIR 99021 Trihydrochloride: GSK-3 Inhibitor for Organoid...
2025-09-30
CHIR 99021 trihydrochloride stands out as a cell-permeable GSK-3 inhibitor, revolutionizing stem cell maintenance, differentiation, and organoid workflows with precise, tunable control. Discover how its robust kinase inhibition enables optimized experimental designs and troubleshooting for next-generation metabolic, diabetes, and cancer biology research.
-
Tamoxifen: Molecular Switches for Precision Immunomodulation
2025-09-29
Explore how tamoxifen, a selective estrogen receptor modulator, is revolutionizing precision immunomodulation and translational research. This article uniquely connects tamoxifen’s molecular mechanisms to cutting-edge T cell biology, gene editing, antiviral strategies, and novel insights in recurrent airway disease.
-
Paclitaxel (Taxol) in Tumor Microenvironment Models: A Ne...
2025-09-28
Discover how Paclitaxel (Taxol), a leading microtubule polymer stabilizer, is unlocking new insights into cancer biology using advanced assembloid models. Explore its unique role in modulating microtubule dynamics, cell cycle arrest, and anti-angiogenic mechanisms for next-generation cancer research.
-
Neomycin Sulfate in Mechanistic Nucleic Acid and Ion Chan...
2025-09-27
Discover the multifaceted capabilities of Neomycin sulfate, an aminoglycoside antibiotic, in advanced RNA/DNA structure interaction studies and ion channel function research. This article provides a unique, mechanism-focused analysis and explores emerging applications in immunology and microbiome modulation.
-
Pioglitazone as a Precision Tool for Decoding PPARγ Signa...
2025-09-26
Explore how Pioglitazone, a potent PPARγ agonist, drives precision research in type 2 diabetes mellitus and neurodegeneration by dissecting the PPAR signaling pathway, beta cell preservation, and inflammatory modulation. This article offers a unique, technical perspective on experimental design, translational insights, and advanced mechanistic applications.
-
3X (DYKDDDDK) Peptide: Precision Tools for Decoding Viral...
2025-09-25
Explore how the 3X (DYKDDDDK) Peptide advances affinity purification of FLAG-tagged proteins and deciphers viral-host mRNA export disruption. This article uniquely connects the peptide's biochemical versatility to cutting-edge virology and translational research.
-
2025-09-24
Discover how CHIR 99021 trihydrochloride, a potent GSK-3 inhibitor, is reshaping advanced organoid engineering by enabling reversible, tunable control over stem cell renewal and differentiation—a unique perspective informed by recent breakthroughs in human intestinal organoid systems.
-
L1023 Anti-Cancer Compound Library: Empowering PLAC1-Targ...
2025-09-23
-
Differentiation of skeletal myoblasts is a tightly orchestra
2025-03-03

Differentiation of skeletal myoblasts is a tightly orchestrated process that involves myoblast proliferation, pkg inhibitor withdrawal, expression of muscle-specific genes, and fusion into multinucleated myofibers (Horsley and Pavlath, 2004; Krauss, 2010). The maintenance of muscle mass is important
-
As an alternative to chronic receptor blockade we
2025-03-03

As an alternative to chronic receptor blockade, we have been targeting adenosine kinase (ADK) – an astrocyte-based enzyme that catalyses the phosphorylation of adenosine, as a means to modify atpase inhibitor adenosinergic signalling (Boison, 2006, Etherington et al., 2009). Up-regulating ADK facil
-
A borderline significant effect of women s age has
2025-03-03

A borderline significant effect of women's age has been observed for ADA6 only. For ADA2 the proportion of the *1/*1 genotype is 69.4% in women aged ≤36 years vs. 66.9% in women aged ≥36 years (p=0.944). The proportion of ADA6*1 allele carriers is 32.6% in women aged ≤36 years vs. 49. 8 in women age
-
LJI308 br Methodology In this paper
2025-03-03

Methodology In this paper, mechanical properties of G-actin are examined. To do so, three different external tensile loads are exerted to the protein. As illustrated in Fig. 1, Arp2/3 complex binds to the one sides of mother LJI308 and leads to the growth of a new daughter filament at a distinct
-
br Acknowledgment br Introduction Vascular smooth
2025-03-03

Acknowledgment Introduction Vascular smooth muscle cells (VSMC) exhibit the capacity to switch between a differentiated (contractile) and a dedifferentiated (synthetic) phenotype [1]. Synthetic VSMC express a lower amount of contractile proteins such as Smooth muscle 22α (sm22α) and α-Smooth m
-
By promoting bundling and processive elongation of actin
2025-03-03

By promoting bundling and processive elongation of Cyanidin Chloride filaments and inhibiting association of capping protein with filament barbed ends, Ena/VASP family proteins contribute to the dynamics of lamellipodia and filopodia [41] and maintenance of focal adhesions and tight junctions [42,
-
Conclusion Twenty compounds with dinitrobenzoate
2025-03-03

Conclusion Twenty compounds with 3,5-dinitrobenzoate scaffold were synthesized and evaluated using cell-free and HWB assays for their 5-LOX inhibition activities. Compared to the parent compound, six compounds show significantly increased enzyme inhibition activities. The best compound, 3-tolyl 3,5
8530 records 33/569 page Previous Next First page 上5页 3132333435 下5页 Last page